The review synthesizes evidence on whether Alzheimer’s disease medications can improve neurocognitive outcomes in children ...
Drugs that act on NMDA (N-methyl-D-aspartate) receptors, which are essential for learning, memory and moment-by-moment consciousness, are key for treating neuropsychiatric disorders. These drugs were ...
Surprising findings published in PNAS have implications for understanding and treating neurological and neuropsychiatric disorders.